1992
DOI: 10.1016/0020-7292(92)90954-h
|View full text |Cite
|
Sign up to set email alerts
|

Immunoreactive circulating endothelin‐1 in normal and hypertensive pregnancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
29
1
2

Year Published

1998
1998
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(38 citation statements)
references
References 0 publications
6
29
1
2
Order By: Relevance
“…In this study, a significant increase in plasma ET-1 level and Th1:Th2 imbalance was observed in patients with preeclampsia which was in accordance with results of previous studies [1][2][3][4][10][11][12]. In addition, there were significant correlations between plasma ET-1 levels and Th2 cells in patients with preeclampsia and in all subjects in general.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…In this study, a significant increase in plasma ET-1 level and Th1:Th2 imbalance was observed in patients with preeclampsia which was in accordance with results of previous studies [1][2][3][4][10][11][12]. In addition, there were significant correlations between plasma ET-1 levels and Th2 cells in patients with preeclampsia and in all subjects in general.…”
Section: Discussionsupporting
confidence: 81%
“…In preeclampsia, an increase in the maternal circulation of strong vasoconstrictor factors such as endothelin 1 (ET-1) has been reported [1][2][3][4]. However, the origin of this increase in preeclampsia remains to be elucidated, although most investigators have hypothesized that it may be caused by systemic endothelial cell activation or dysfunction [1,5].…”
Section: Introductionmentioning
confidence: 97%
“…In interference with relaxation factors, ET-1 plays an important role in regulating blood flow and blood pressure [17,18]. Previous reports on ET-1 concentrations in peripheral maternal plasma in patients with pre-eclampsia have been contradictory, some showing increased [4][5][6] and some normal values [7,8].…”
Section: Introductionmentioning
confidence: 98%
“…It has been demonstrated that multiple mechanisms contribute to the increased vascular resistance during PE, including increased vascular sensitivity to angiotensin II (ANG II) [4,5], the presence of angiotensin II receptor-1 (AT 1 ) autoantibody [2,6], an imbalance between the vasoconstrictor thromboxane (TX) and decreased vasodilator prostacyclin (PGI2) [7,8], and altered endothelin (ET) [9,10] and nitric oxide (NO) [11] levels in both the maternal circulation and in the placenta in women with PE. These alterations may result in a detrimental positive feedback system that promotes inflammation and further vasoconstriction.…”
Section: Introductionmentioning
confidence: 99%